Benzinga | Jan 14, 2021 08:34AM EST

Artelo Biosciences Q1 EPS $(0.14) Beats $(0.38) Estimate

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.38) by 63.16 percent. This is a 65 percent increase over losses of $(0.40) per share from the same period last year.